Table 2.
Interval between date of onset of symptoms and the date of first medical consultation that led to referral for cancer diagnosis (access delay) and its determinants.
| Characteristics | Longest duration of symptoms (months) |
Crude |
Adjusted∗ |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1–5 |
6–11 |
12+ |
Risk ratio (95% CI) | Risk ratio (95% CI) | ||||||||
| n (%) | n (%) | n (%) | ||||||||||
| Patients with symptoms | 850 | 433 | 549 | |||||||||
| Centre | ||||||||||||
| CM-VI, Casablanca | 370 | (46.2) | 183 | (22.8) | 248 | (31.0) | 1.00 | 1.00 | ||||
| INO, Rabat |
480 |
(46.6) |
250 |
(24.2) |
301 |
(29.2) |
0.98 |
(0.88 - |
1.07) |
0.95 |
(0.86 - |
1.03) |
| Period of diagnosis | ||||||||||||
| 2008–2012 | 337 | (40.3) | 224 | (26.8) | 275 | (32.9) | 1.00 | 1.00 | ||||
| 2013–2017 |
513 |
(51.5) |
209 |
(21.0) |
274 |
(27.5) |
0.79 |
(0.72 - |
0.86) |
0.76 |
(0.67 - |
0.85) |
| Age at diagnosis (years) | ||||||||||||
| <30 | 19 | (52.8) | 9 | (25.0) | 8 | (22.2) | 1.00 | 1.00 | ||||
| 30-39 | 145 | (49.0) | 87 | (29.4) | 64 | (21.6) | 1.14 | (0.78 - | 1.59) | 1.19 | (0.83 - | 1.67) |
| 40-49 | 321 | (50.6) | 140 | (22.1) | 173 | (27.3) | 1.11 | (0.96 - | 1.27) | 1.12 | (0.96 - | 1.28) |
| 50-59 | 226 | (43.4) | 117 | (22.5) | 178 | (34.2) | 1.25 | (1.07 - | 1.43) | 1.22 | (1.01 - | 1.44) |
| 60-69 | 99 | (41.1) | 59 | (24.5) | 83 | (34.4) | 1.38 | (1.15 - | 1.62) | 1.33 | (1.05 - | 1.60) |
| 70+ |
39 |
(37.9) |
21 |
(20.4) |
43 |
(41.7) |
1.54 |
(1.21 - |
1.92) |
1.50 |
(1.13 - |
1.90) |
| Residence | ||||||||||||
| Urban | 672 | (46.5) | 346 | (23.9) | 428 | (29.6) | 1.00 | 1.00 | ||||
| Semi-urban | 73 | (44.8) | 38 | (23.3) | 52 | (31.9) | 0.99 | (0.84 - | 1.16) | 1.01 | (0.86 - | 1.19) |
| Rural |
105 |
(47.1) |
49 |
(22.0) |
69 |
(30.9) |
0.97 |
(0.84 - |
1.11) |
1.03 |
(0.89 - |
1.19) |
| Health insurance coverage | ||||||||||||
| None | 214 | (39.6) | 146 | (27.0) | 180 | (33.3) | 1.00 | 1.00 | ||||
| RAMed | 422 | (51.0) | 174 | (21.0) | 232 | (28.0) | 0.83 | (0.74 - | 0.92) | 1.02 | (0.89 - | 1.17) |
| Employee's insurance |
120 |
(48.0) |
55 |
(22.0) |
75 |
(30.0) |
1.01 |
(0.86 - |
1.17) |
1.13 |
(0.96 - |
1.31) |
| Marital status | ||||||||||||
| Never married | 129 | (46.9) | 62 | (22.5) | 84 | (30.5) | 1.00 | 1.00 | ||||
| Ever married |
669 |
(45.9) |
354 |
(24.3) |
433 |
(29.7) |
1.02 |
(0.89 - |
1.15) |
1.05 |
(0.88 - |
1.24) |
| Parity | ||||||||||||
| None | 181 | (45.8) | 92 | (23.3) | 122 | (30.9) | 1.00 | 1.00 | ||||
| 1-2 | 196 | (45.4) | 121 | (28.0) | 115 | (26.6) | 0.97 | (0.83 - | 1.12) | 0.92 | (0.78 - | 1.10) |
| 3-4 | 232 | (50.4) | 95 | (20.7) | 133 | (28.9) | 0.84 | (0.73 - | 0.97) | 0.82 | (0.69 - | 0.96) |
| 5+ |
174 |
(44.8) |
95 |
(24.5) |
119 |
(30.7) |
0.96 |
(0.82 - |
1.10) |
0.84 |
(0.69 - |
0.99) |
| Menopause status | ||||||||||||
| No | 465 | (50.0) | 225 | (24.2) | 240 | (25.8) | 1.00 | 1.00 | ||||
| Yes |
334 |
(42.7) |
182 |
(23.2) |
267 |
(34.1) |
1.27 |
(1.15 - |
1.40) |
1.13 |
(0.99 - |
1.30) |
| Family history of breast cancer | ||||||||||||
| No | 693 | (46.7) | 350 | (23.6) | 440 | (29.7) | 1.00 | 1.00 | ||||
| Yes | 98 | (44.5) | 58 | (26.4) | 64 | (29.1) | 1.13 | (0.97 - | 1.31) | 1.14 | (0.98 - | 1.32) |
CM-VI: Centre Mohammed VI pour le traitement des cancers; INO: Institut National d’Oncologie; RAMed: Régime d’Assistance Médicale; CI: Confidence Interval; ∗ Adjusted for all the variables listed in the table.